Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$18.33 +0.88 (+5.04%)
As of 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$17.43
$18.50
50-Day Range
$12.53
$18.23
52-Week Range
$8.89
$24.50
Volume
343,868 shs
Average Volume
530,013 shs
Market Capitalization
$796.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.56
Consensus Rating
Moderate Buy

Company Overview

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBNX Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX stock has decreased by 23.0% and is now trading at $18.33.

Beta Bionics, Inc. (NASDAQ:BBNX) released its quarterly earnings data on Tuesday, July, 29th. The company reported ($0.39) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.51) by $0.12. The company earned $23.24 million during the quarter, compared to analysts' expectations of $19.73 million.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

Beta Bionics's lock-up period expired on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Since the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Beta Bionics' top institutional investors include Eventide Asset Management LLC (11.35%), Soleus Capital Management L.P. (8.79%), Sands Capital Alternatives LLC (8.21%) and Divisadero Street Capital Management LP (2.18%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/29/2025
Today
8/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
CIK
1674632
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$16.00
Potential Upside/Downside
+29.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.68
Quick Ratio
13.79

Sales & Book Value

Annual Sales
$78.02 million
Price / Sales
9.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.72) per share
Price / Book
-3.05

Miscellaneous

Outstanding Shares
43,470,000
Free Float
N/A
Market Cap
$758.55 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners